Matthieu Foll
Overview
Explore the profile of Matthieu Foll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
4210
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-Cuesta L, Alcala N, Mathian E, Derks J, Thirlwell C, Dayton T, et al.
J Clin Invest
. 2025 Mar;
135(5).
PMID: 40026252
Neuroendocrine tumors (NETs) are a diverse group of malignancies that can occur in various organs, with a notable prevalence in the lungs and gastrointestinal tract, which are the focus of...
2.
Understanding the biological processes of kidney carcinogenesis: an integrative multi-omics approach
Penha R, Sexton Oates A, Senkin S, Park H, Atkins J, Holcatova I, et al.
Mol Syst Biol
. 2024 Nov;
20(12):1282-1302.
PMID: 39592856
Biological mechanisms related to cancer development can leave distinct molecular fingerprints in tumours. By leveraging multi-omics and epidemiological information, we can unveil relationships between carcinogenesis processes that would otherwise remain...
3.
Leunissen D, Moonen L, von der Thusen J, den Bakker M, Hillen L, van Weert T, et al.
J Thorac Oncol
. 2024 Nov;
PMID: 39581377
Introduction: Multi-omic studies have identified three molecular separated pulmonary carcinoid (PC) subgroups (A1, A2, B) with distinctive mRNA expression profiles (e.g., orthopedia homeobox protein [OTP], achaete-scute homolog [ASCL1], and hepatocyte...
4.
Werr L, Bartenhagen C, Rosswog C, Cartolano M, Voegele C, Sexton-Oates A, et al.
J Clin Oncol
. 2024 Sep;
43(2):214-225.
PMID: 39348606
Purpose: The clinical course of pulmonary carcinoids ranges from indolent to fatal disease, suggesting that specific molecular alterations drive progression toward the fully malignant state. A similar spectrum of clinical...
5.
Koumarianou A, Filosso P, Bodei L, Castano J, Fernandez-Cuesta L, Deroose C, et al.
J Neuroendocrinol
. 2024 May;
36(8):e13412.
PMID: 38754956
Lung carcinoid tumours are neuroendocrine neoplasms originating from the bronchopulmonary tract's neuroendocrine cells, accounting for only 1%-3% of all lung cancers but 30% of all neuroendocrine tumours. The incidence of...
6.
Alcala N, Voegele C, Mangiante L, Sexton-Oates A, Clevers H, Fernandez-Cuesta L, et al.
Gigascience
. 2024 Mar;
13.
PMID: 38451475
Background: Organoids are 3-dimensional experimental models that summarize the anatomical and functional structure of an organ. Although a promising experimental model for precision medicine, patient-derived tumor organoids (PDTOs) have currently...
7.
Dayton T, Alcala N, Moonen L, den Hartigh L, Geurts V, Mangiante L, et al.
Cancer Cell
. 2023 Dec;
41(12):2083-2099.e9.
PMID: 38086335
Neuroendocrine neoplasms (NENs) comprise well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Treatment options for patients with NENs are limited, in part due to lack of accurate models....
8.
Blazquez-Encinas R, Garcia-Vioque V, Caro-Cuenca T, Moreno-Montilla M, Mangili F, Alors-Perez E, et al.
J Transl Med
. 2023 Dec;
21(1):879.
PMID: 38049848
Background: Lung neuroendocrine neoplasms (LungNENs) comprise a heterogeneous group of tumors ranging from indolent lesions with good prognosis to highly aggressive cancers. Carcinoids are the rarest LungNENs, display low to...
9.
Fernandez-Cuesta L, Sexton-Oates A, Bayat L, Foll M, Lau S, Leal T
Am Soc Clin Oncol Educ Book
. 2023 May;
43:e390794.
PMID: 37229617
Lung neuroendocrine neoplasms (NENs) encompass a spectrum of neoplasms that are subdivided into the well-differentiated neuroendocrine tumors comprising the low- and intermediate-grade typical and atypical carcinoids, respectively, and the poorly...
10.
Mangiante L, Alcala N, Sexton-Oates A, Di Genova A, Gonzalez-Perez A, Khandekar A, et al.
Nat Genet
. 2023 Mar;
55(4):607-618.
PMID: 36928603
Malignant pleural mesothelioma (MPM) is an aggressive cancer with rising incidence and challenging clinical management. Through a large series of whole-genome sequencing data, integrated with transcriptomic and epigenomic data using...